| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Bictegravir alters glucose tolerance in vivo and causes hepatic mitochondrial dysfunction
|
García-Martínez, Patricia
|
|
|
231 |
C |
p.
|
article
|
| 2 |
Bithiazole inhibitors of PI4KB show broad-spectrum antiviral activity against different viral families
|
Martina, Maria Grazia
|
|
|
231 |
C |
p.
|
article
|
| 3 |
Circulating capsid-antibody-complexes (CACs) drive intrahepatic complement deposition and inform subclinical liver inflammation in chronic hepatitis B
|
Tang, Yijie
|
|
|
231 |
C |
p.
|
article
|
| 4 |
Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database (CHARMD)
|
Tilloy, Valentin
|
|
|
231 |
C |
p.
|
article
|
| 5 |
Coronavirus nucleocapsid-based vaccine provides partial protection against hetero-species coronavirus in murine models
|
Lee, Pureum
|
|
|
231 |
C |
p.
|
article
|
| 6 |
Corrigendum to “Discovery of ZFD-10 of a pyridazino[4,5-b]indol-4(5H)-one derivative as an anti-ZIKV agent and a ZIKV NS5 RdRp inhibitor” [Antivir. Res. 214 (2023) 105607]
|
Zhou, Guang-Feng
|
|
|
231 |
C |
p.
|
article
|
| 7 |
CXCR7 genetic variant predicts treatment response of pegylated-interferon α in HBeAg-positive chronic hepatitis B patients
|
Luo, Mengqi
|
|
|
231 |
C |
p.
|
article
|
| 8 |
Dendritic cell-based biomimetic nanoparticles for foot-and-mouth disease induce robust cellular immunity
|
Gao, Zhan
|
|
|
231 |
C |
p.
|
article
|
| 9 |
Design and biological evaluation of candidate drugs against zoonotic porcine deltacoronavirus (PDCoV)
|
Zhou, Junwei
|
|
|
231 |
C |
p.
|
article
|
| 10 |
Dynamic features of virus protein 1 and substitutions in the 3-phenyl ring determine the potency and broad-spectrum activity of capsid-binding pyrazolo[3,4-d]pyrimidines against rhinoviruses
|
Richter, Martina
|
|
|
231 |
C |
p.
|
article
|
| 11 |
Editorial Board
|
|
|
|
231 |
C |
p.
|
article
|
| 12 |
Evaluation of pharmacokinetics of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil (TDF) in pregnant and postpartum women in South Africa: PrEP-PP PK study
|
Joseph Davey, Dvora
|
|
|
231 |
C |
p.
|
article
|
| 13 |
Functional comparison of Fc-engineering strategies to improve anti-HIV-1 antibody effector functions
|
Schriek, Angela I.
|
|
|
231 |
C |
p.
|
article
|
| 14 |
Highly specific SARS-CoV-2 main protease (Mpro) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system
|
Rauch, Stefanie
|
|
|
231 |
C |
p.
|
article
|
| 15 |
Identification of antibody-resistant SARS-CoV-2 mutants via N4-Hydroxycytidine mutagenesis
|
Kumar, Priya
|
|
|
231 |
C |
p.
|
article
|
| 16 |
Inhibitory peptides derived from Hepatitis C virus NS5A for reducing clinical symptoms of dengue virus infection
|
Lee, Younghoon
|
|
|
231 |
C |
p.
|
article
|
| 17 |
Large-scale deep learning identifies the antiviral potential of PKI-179 and MTI-31 against coronaviruses
|
van der Horst, Demi
|
|
|
231 |
C |
p.
|
article
|
| 18 |
MβCD inhibits SFTSV entry by disrupting lipid raft structure of the host cells
|
Cheng, Min
|
|
|
231 |
C |
p.
|
article
|
| 19 |
Modulating apoptosis as a novel therapeutic strategy against Respiratory Syncytial Virus infection: insights from Rotenone
|
Zhang, Ke
|
|
|
231 |
C |
p.
|
article
|
| 20 |
Novel intercellular spread mode of respiratory syncytial virus contributes to neutralization escape
|
Zhang, Wei
|
|
|
231 |
C |
p.
|
article
|
| 21 |
Optimization of Bangladesh and Malaysian genotype recombinant reporter Nipah viruses for in vitro antiviral screening and in vivo disease modeling
|
Lo, Michael K.
|
|
|
231 |
C |
p.
|
article
|
| 22 |
Orally bioavailable RORγ/DHODH dual host-targeting small molecules with broad-spectrum antiviral activity
|
Herrmann, Alexandra
|
|
|
231 |
C |
p.
|
article
|
| 23 |
Preclinical and clinical antiviral characterization of AB-836, a potent capsid assembly modulator against hepatitis B virus
|
Lam, Angela M.
|
|
|
231 |
C |
p.
|
article
|
| 24 |
Replication capacity and susceptibility of nirmatrelvir-resistant mutants to next-generation Mpro inhibitors in a SARS-CoV-2 replicon system
|
Lo, Chieh-Wen
|
|
|
231 |
C |
p.
|
article
|
| 25 |
Structural and quantitative comparison of viral infection-associated N-glycans in plasma from humans, pigs, and chickens: Greater similarity between humans and chickens than pigs
|
Kim, Mirae
|
|
|
231 |
C |
p.
|
article
|
| 26 |
The ApoA1-mimetic peptide 4F blocks flavivirus NS1-triggered endothelial dysfunction and protects against lethal dengue virus challenge
|
Carneiro, Pedro H.
|
|
|
231 |
C |
p.
|
article
|
| 27 |
The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model
|
Do, Thuc Nguyen Dan
|
|
|
231 |
C |
p.
|
article
|
| 28 |
Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates
|
Prévost, Jérémie
|
|
|
231 |
C |
p.
|
article
|
| 29 |
Vemurafenib inhibits the replication of diabetogenic enteroviruses in intestinal epithelial and pancreatic beta cells
|
Butrym, Marta
|
|
|
231 |
C |
p.
|
article
|
Journal description